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Excess smooth muscle accumulation is a key
component of many vascular disorders, including
atherosclerosis, restenosis, and pulmonary artery
hypertension, but the underlying cell biological
processes are not well defined. In pulmonary artery
hypertension, reduced pulmonary artery compliance
is a strong independent predictor of mortality, and
pathological distal arteriole muscularization contrib-
utes to this reduced compliance. We recently
demonstrated that embryonic pulmonary artery wall
morphogenesis consists of discrete developmentally
regulated steps. In contrast, poor understanding of
distal arteriole muscularization in pulmonary artery
hypertension severely limits existing therapies that
aim to dilate the pulmonary vasculature but have
modest clinical benefit and do not prevent hyper-
muscularization. Here, we show that most patholog-
ical distal arteriole smooth muscle cells, but not
alveolar myofibroblasts, derive from pre-existing
smooth muscle. Furthermore, the program of distal
arteriole muscularization encompasses smooth
muscle cell dedifferentiation, distal migration, prolif-
eration, and then redifferentiation, thereby recapitu-
lating many facets of arterial wall development.INTRODUCTION
Novel efficacious treatments for pulmonary artery hypertension
(PAH) are desperately needed, given that this disease is highly
morbid and lethal; indeed, 45% of patients die within three
years of initial diagnosis (Humbert et al., 2010). The histopatho-
logical findings of PAH include an increased smooth muscle
cell (SMC) burden with distal extension of SMCs to normally
nomuscularized pulmonary arterioles (Farber and Loscalzo,
2004). PAH results from increased resistance to flow through
the pulmonary vasculature, and decreased compliance of mus-
cularized distal arterioles is an important contributor (Rabino-vitch, 2008). Furthermore, in PAH, reduced compliance of the
pulmonary arterial vasculature is a strong independent predictor
of mortality (Mahapatra et al., 2006). Existing medical therapies
for PAH primarily lower pulmonary artery (PA) blood pressure
through vasodilation but have modest clinical efficacy and
limited ameliorative effects on SMC differentiation, migration or
recruitment.
This void in therapeutic options for PAH is striking but perhaps
not surprising, because our understanding of the molecular and
cellular processes underlying arteriole muscularization is limited.
Many signaling pathways contribute to PAH pathology (Kim
et al., 2013; Rabinovitch, 2008), and although a number of
cellular sources of the pathological distal arteriole SMCs have
been implicated (Morrell et al., 2009; Stenmark et al., 2006),
the origin of these SMCs remains to be defined. In addition,
increased alpha smooth muscle actin (SMA)+ alveolar myofibro-
blasts have been observed in human pulmonary hypertension
(PH) (Kapanci et al., 1990), but their pathogenesis has not been
analyzed. We recently demonstrated that construction of the
embryonic PA wall is composed of discrete developmentally
regulated steps involving progenitor recruitment, migration,
differentiation, and proliferation (Greif et al., 2012). Herein,
through meticulous analysis of three pulmonary arteriole beds
and surrounding alveoli, we now show that in hypoxia-induced
PH, the distal arteriole SMCs, but not alveolar myofibroblasts,
derive from pre-existing SMC marker+ cells. Furthermore, this
distal arteriole muscularization encompasses a tightly regulated
pathological program in which SMCs undergo dedifferentiation,
distal migration, proliferation, and then redifferentiation, thereby
recapitulating many aspects of the developmental program.
RESULTS
Specific Nonmuscularized Distal Arterioles Become
Muscularized with Hypoxia
Currently, the extent of pulmonary vascular remodeling in PH
is assessed by crudely grading themuscular coverage of individ-
ual small arterioles on random lung sections. Recently, we un-
covered key insights by meticulously analyzing the construction
of the wall of a small region of the left PA during normal embryo-
genesis (Greif et al., 2012), and herein, we have developed a
similar reductionist approach to examine pulmonary arterioleCell Reports 6, 809–817, March 13, 2014 ª2014 The Authors 809
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muscularization during PH onset in the adult mouse. This
approach is facilitated by the stereotyped and similar pulmonary
arterial and airway branching patterns, allowing for reproducible
identification of specific arteriole beds (Figures S1A–S1C). We
focus on three vascular beds located in the cranial and medial
aspects of the adult left lung (Figures 1A, 1B, 1B0, and 1B00)
and categorize the arteriole segments in each of these vascular
beds (by both position in the vascular tree and lumen diameter)
as proximal (>75 mm distal), middle (25–75 mm), or distal
(<25 mm). Proximal and middle arterioles are coated by SMCs,
whereas distal arterioles are not muscularized and extend from
the middle arteriole to the capillary bed. Thus, under normal
conditions, the middle-distal (M-D) arteriole border, a fixed
anatomical border, coincides with the transition from muscular-
ized to unmuscularized arteriole.
Hypoxia is a well-established independent cause of human
PH and also exacerbates PH due to other etiologies, such as
PAH and parenchymal lung disease (Stenmark et al., 2006).
Mice exposed to hypoxia (FiO2 10%) for 3 weeks develop PH
(Figure S1D) (Stenmark et al., 2006), and we noted significant
right ventricle (RV) hypertrophy by 2 weeks and increasing
hypertrophy over the subsequent week (Figure S1E). Impor-
tantly, with chronic hypoxia treatment, unmuscularized distal
arterioles in the aforementioned vascular beds become muscu-
larized with SMA+ cells (Figure 1C). Thus, in contrast to the fixed
M-D border, the muscular-unmuscular transition zone is
dynamic, moving distally with hypoxia. This distal extension of
SMC coverage to normally nonmuscularized pulmonary arteri-
oles is a hallmark of human PH (Shimoda and Laurie, 2013).
Distal Pulmonary Arteriole SMCs Derive from Pre-
existing SMCs
To determine whether pre-existing SMCs give rise to distal
pulmonary arteriole SMCs during PH, we carried out lineage
tracing with the CreER-loxP system. Tamoxifen treatment of
normoxic mice carrying SMA-CreERT2 (Wendling et al., 2009)Figure 1. Muscularization of Specific Distal Arterioles with Hypoxia
(A) Schematic of proximal PA (green) and airway (gray) branches of left lung (ventra
unmuscularized distal arteriole beds that becomemuscularized with hypoxia. The
is in proximity to airway branch L.L1.A1.M1 (i.e., left bronchus-first lateral seconda
main bronchus; L1, L2, L3, lateral branches; M1, M2, medial branches; A1, ante
(B and C) Left lungs stained for SMA (SMC marker, red), von Willebrand factor (
white), and nuclei (DAPI, blue). The lungs shown in (B) and (C) are harvested fro
respectively. The boxed region of the vibratome coronal section in (B) is shown at h
arteriole bed of interest is boxed and shown at higher power in (B00). The line and a
arterioles, respectively. In (C), the distal arterioles are coated by SMA+ cells up t
(D and E) Left lungs of adultSMA-CreER, ROSA26R(mTmG/mTmG)mice inducedwith
hypoxia for 3 weeks prior to imaging (E). Lungs were stained for SMA (red), GFP (C
adjacent alveoli in proximity to airway L.L1.A1.L1 are shown in (D). The boxed reg
the L.M1 airway branch (see A, lower black box) that we previously identified beco
arteriole (art) are marked with the lineage tag (GFP).
(F) Quantification of the percent of arteriole SMA+ cells that are GFP+, stratified b
distal (D; <25 mm). The number of each pulmonary arteriole type analyzed and SM
hypoxia (P: 5, 207; M: 8, 348; D: 9, 115).
(G) Confocal image of alveoli adjacent to distal muscularized arteriole (art; L.L
tamoxifen and hypoxia and stained as in (E). Note that arteriole SMCs, but not alv
(H) Quantification of the percent of alveolar myofibroblasts (myoFBs) that expres
shown in (F). The number of SMA+ cells scored in the distal arterioles and alveol
Error bars in (F) and (H) indicate SD. Scale bars represent 1 mm (B), 100 mm (B0)and the Cre reporter ROSA26R(mTmG/mTmG) (Muzumdar et al.,
2007) induces marking of SMCs (Figures 1D and S2), and after
the labeling phase (i.e., 5 days of tamoxifen [1 mg/day] and
5 days of rest), 95% of PA SMCs express the GFP lineage
tag (Figure 1F, normoxia). We then analyzed the expression of
GFP in pulmonary arterioles of the aforementioned vascular
beds (see Figure 1A) of SMA-CreER, ROSA26R(mTmG/mTmG)
mice following tamoxifen labeling, rest, and then 3 weeks of
hypoxia. Interestingly, >80% of the distal pulmonary arteriole
SMCs were GFP+ (Figures 1E, 1E0, and 1F), indicating that
pre-existing SMCs are the major source of hypoxia-induced
distal arteriole smooth muscle. These studies fate map SMCs
in PH and, along with our prior developmental studies (Greif
et al., 2012), indicate that SMC migration along the axial direc-
tion of uncoated endothelial cell (EC) tubes is common to both
the developmental and pathological programs of arterial
muscularization.
Hypoxia-Induced Myofibroblasts Primarily Derive from
SMA Cells
Alveolar myofibroblasts increase in quantity during the first 2
postnatal weeks and are key players in alveolar septal formation
during alveologenesis (Choi, 2010; McGowan and McCoy,
2011). Herein, we observed that the number of elongated alve-
olar SMA+ myofibroblasts decreases by postnatal week 4 as
compared to week 2, and this diminution continues until they
are essentially absent in adulthood (Figures S3A and S3C). Alve-
olar myofibroblasts have been shown to accumulate in human
PH (Kapanci et al., 1990) and increase in mice after exposure
to hypoxia for 6 weeks (Chen et al., 2006). Our studies indicate
that the number of myofibroblasts increases significantly within
7 days of hypoxia and continues to do so over the next 2 weeks
(Figures S3B and S3C). We then utilized lineage analysis with
SMA-CreERT2, ROSA26R(mTmG/mTmG)mice induced with tamox-
ifen and determined that in contrast to distal pulmonary arteriole
SMCs, >75% of the alveolar myofibroblasts induced by hypoxial view). The three boxes indicate regions where we have reproducibly identified
red box indicates the arteriole bed shown in (B0), (B00), and (C). This arteriole bed
ry branch-first anterior branch-first medial branch) (Metzger et al., 2008). L, left
rior branch.
vWF; expressed by ECs of larger vessels, green), MECA-32 (pan-EC marker,
m adult mice after exposure to normoxia or hypoxia (FiO2 10%) for 3 weeks,
igher power in (B0 ). In (B0), muscularized airways are indicated by ‘‘aw,’’ and the
rrowheads in (B00) indicate the muscularized middle and unmuscularized distal
o the transition to capillaries as shown by the asterisk.
tamoxifen, rested for 5 days, and then either confocal imaged (D) or exposed to
re reporter, green), and MECA-32 (white). A muscularized middle arteriole and
ion in (E) (shown at higher power in E0) contains a distal arteriole in proximity to
mes muscularized with hypoxia. Note that hypoxia-induced SMCs of the distal
y arteriole location/diameter as proximal (P; >75 mm), middle (M; 25–75 mm), or
A+ cells scored were: normoxia (P: 2 arterioles, 151 cells; M: 3, 181; D: 3; 0) and
1.A.L1) from a SMA-CreER, ROSA26R(mTmG/mTmG) mouse both treated with
eolar SMA+ cells (indicated by arrowhead), are marked by the GFP lineage tag.
s GFP with hypoxia and compared to this percent for distal arteriole SMCs as
i were 115 (PA SMC) and 265 (myoFB), respectively.
, and 25 mm (C, D, E, E0, and G). See also Figures S1–S3.
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Figure 2. Dynamic and Distinct Expression of SMA and SMMHC during Hypoxia-Induced Distal Pulmonary Arteriole Muscularization
(A–D) Adult mice were exposed to normoxia or to hypoxia for 3, 7, and 21 days as indicated, and then left lungs were stained for SMA (red), SMMHC (green),
MECA-32 (white), and nuclei (DAPI, blue). Representative confocal images of arteriole beds located in proximity to L.L1.A1 airway branches. The boxed regions in
the merged images are shown as close-ups below with asterisks and open arrowheads representing SMA+SMMHC+ and SMA+ cells, respectively. Note the
transitory downregulation of SMMHC in SMA+ cells in the distal arteriole at 3 and 7 days of hypoxia. Scale bar, 25 mm. See also Figures S3 and S4.are GFP and thus arise from SMA cells that were present
prior to hypoxia treatment (Figures 1G and 1H). Prior studies
have not utilized genetic tracing to evaluate the cellular origin
of hypoxia-induced alveolar myofibroblasts.
Initial Distal Arteriole Muscularization Involves SMC
Dedifferentiation
We next examined a timeline of cellular and molecular events
during SMC invasion of distal arterioles with PH onset. We first
evaluated the normoxia and initial week of hypoxia time periods,
focusing on the expression patterns of SMA, the differentiated
SMC marker smooth muscle myosin heavy chain (SMMHC),
and the undifferentiated mesenchymal marker platelet-derived
growth factor receptor-b (PDGFR-b; Figures 2, 3, and S4). Under
normoxic conditions, SMMHC and SMA are expressed in the
same pulmonary arteriole cells (Figures 2A and S4A), whereas
arteriole PDGFR-b expression is limited to a few SMC marker+812 Cell Reports 6, 809–817, March 13, 2014 ª2014 The Authorscells located at or near the muscular-unmuscular transition
zone (i.e., the normoxic M-D border; Figures 3A, 3A0, and
S4A). By day 3 of hypoxia, a few SMA+SMMHC cells are
located just distal to the M-D border (Figure 2B), and many of
these cells express PDGFR-b (Figures 3B and S4B). Given the
fate-mapping findings (Figures 1E and 1F), we suggest these
cells derive from pre-existing arteriole SMCs and upon hypoxia
exposure dedifferentiate (i.e., decrease SMMHC expression and
increase PDGFR-b expression) and migrate across the M-D
border. By day 7 of hypoxia, the process of arteriole musculari-
zation with SMA+SMMHC cells has continued distally down the
arteriole (Figures 2C and S4C), and these SMA+ cells also ex-
press PDGFR-b (Figures 3C and S4C). Meanwhile, the distal
arteriole SMA+ cells located in proximity to the M-D border
have begun to express SMMHC (Figure 2C). SMC dedifferentia-
tion is not observed in normal PA wall morphogenesis (Greif
et al., 2012); however, both the developmental and disease
Figure 3. PDGFR-b Expression Pattern during Hypoxia Indicates Distal Arteriole SMC Dedifferentiation and Redifferentiation
(A–D) Distal arterioles in the aforementioned arteriole beds (see Figure 1A) at the indicated time points of hypoxia stained for SMA (red), PDGFR-b (green), MECA-
32 (white), and nuclei (DAPI, blue). The boxed regions in the merged images are shown as close-ups below with open and closed arrowheads representing SMA+
and SMA+PDGFR-b+ cells, respectively. Note the transitory broad expression of PDGFR-b in distal arteriole SMA+ cells at days 3 and 7 of hypoxia. The close-up in
(A) is shown below (in A0) in individual panels with DAPI and specific channels as well as a merge of all channels. Scale bar, 25 mm. See also Figure S4.muscularization programs are characterized by SMA+ cells that
have transitory expression of PDGFR-b and robustly both
migrate and, as described below, proliferate (see Figures 4A
and 4B).Differentiation of Hypoxia-Induced Arteriole Smooth
Muscle and Alveolar Myofibroblasts
During the second week of hypoxia, SMA+ cells continue to
migrate distally along the pulmonary arteriole and, interestingly,Cell Reports 6, 809–817, March 13, 2014 ª2014 The Authors 813
Figure 4. Hypoxia-Induced Distal Arteriole SMC Proliferation and Schematic of Key Events during Distal Muscularization
(A) Distal arterioles in proximity to L.L1.A1 airway branches at normoxia or indicated days of hypoxia stained for SMA (red), BrdU (green), CD31 (ECmarker, white),
and nuclei (DAPI, blue).
(legend continued on next page)
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by day 14, begin to upregulate SMMHC expression (Figures S4D
and S4F). Concomitantly, PDGFR-b expression is decreasing in
SMA+ cells with SMA+PDGFR-b+ cells detectable in a discontin-
uous fashion in the distal arteriole (Figures S4D and S4G). The
differentiation process continues until day 21 of hypoxia, when
SMA+SMMHC+ cells coat essentially the entire distal arteriole
up to the lung capillaries (Figures 2D and S4E). At this time point,
PDGFR-b is not detectable throughout the pulmonary arteriole,
except for a few SMA+SMMHC+PDGFR-b+ cells located in
proximity to the new muscular-unmuscular transition zone (Fig-
ures 3D and S4E); interestingly, this pattern is similar to what
was noted in the normoxic condition (see Figures 3A and S4A).
Furthermore, this phase of hypoxia-induced distal arteriole
smooth muscle maturation recapitulates the program of normal
embryonic PA wall differentiation in which smooth muscle layers
undergo developmentally regulated and coordinated SMC
marker expression and PDGFR-b downregulation (Greif et al.,
2012).
In addition to hypermuscularization of the pulmonary vascula-
ture, the number of alveolar SMA+ myofibroblasts also progres-
sively increases with hypoxia treatment (see Figures S3B and
S3C). These alveolar SMA+ cells markedly upregulate SMMHC,
with 85% of alveolar SMA+ myofibroblasts also expressing
SMMHC by day 21 of hypoxia (Figures S3D and S3E). In
contrast, PDGFR-b expression was not detected in these cells
at any stage (data not shown).
Distal Arteriole Smooth Muscle Proliferation Peaks at 1
Week of Hypoxia
We then investigated alveolar myofibroblast and pulmonary
arteriole cell proliferation during hypoxia by assessing bromo-
deoxyuridine (BrdU) incorporation 4 hours after a single intraper-
itoneal injection (Figures 4A–4C and S1F). A very low percentage
of alveolar myofibroblasts were proliferative at each time point
evaluated (i.e., normoxia and hypoxia days 3, 7, 14, and 21);
combining all time points, only 4 of the 394 myofibroblasts
scored were BrdU+ (Figure 4C; data not shown). In contrast,
EC proliferation is significantly increased in middle and distal
pulmonary arterioles by day 21 of hypoxia (Figure S1F). Similar
to the myofibroblast results, very rare BrdU+ SMCs in the prox-
imal or middle arteriole were detected under normoxic and all
hypoxic conditions (Figure 4B). Although SMCs begin to migrate
distally by day 3 of hypoxia, only 5% of distal arteriole SMCs
are BrdU+ (Figures 4A and 4B), suggesting that initial musculari-(B) Quantification of proliferating SMCs in proximal (P), middle (M), and distal (D)
arterioles were analyzed for each normoxia or hypoxia condition, and the number
180–205 SMA+ cells), M (each condition, 130–190), or D (normoxia, 0; hypoxia 3 da
arteriole SMC proliferation at days 7 and 14. ε versus normoxia D, p < 0.005; # v
(C) Alveoli and distal arteriole (art) in proximity to L.L1.A1.L1 airway branch at hyp
whereas the alveolar myofibroblasts (arrowheads) do not stain for BrdU.
(D) Summary of molecular and cellular events during hypoxia-induced distal pulm
SMCs are SMA+SMMHC+ (gray), and theD arteriole is notmuscularized. Interestin
to the M-D border (dashed vertical line). By day 3 of hypoxia, the pre-existing SMC
indicated by the expression of PDGFR-b and downregulation of SMMHC (pink)
distally. At day 14, proliferation continues and distal arteriole SMA+ cells start to re
PDGFR-b. By day 21 of hypoxia, essentially the entire distal pulmonary arteriole
normoxic condition, a few SMA+SMMHC+PDGFR-b+ are located adjacent to the
Scale bars, 25 mm. See also Figure S1.zation is driven primarily by migration and not proliferation. In
contrast, by day 7, there is marked upregulation in distal prolifer-
ation with, remarkably, 65% of distal arteriole SMCs staining
for BrdU. Subsequently, this proliferation decreases, and by
21 days of hypoxia, the proliferation rate returns to that of
normoxia. These pathological findings are comparable to our
prior developmental results that at the midpoint of normal em-
bryonic PA morphogenesis, SMA+ wall cells maintain a signifi-
cant proliferative index (Greif et al., 2012).
DISCUSSION
A critical component of the massive burden of cardiovascular
disease on human health is the excessive and ectopic accumu-
lation of SMCs that plagues numerous arterial diseases,
including atherosclerosis, restenosis after balloon angioplasty,
and PAH. Unfortunately, little is known regarding the in vivo
molecular and cellular processes underlying these pathologies,
and this lack of knowledge severely limits therapeutic options
(Gomez and Owens, 2012; Seidelmann et al., 2013). Distal
pulmonary arteriole muscularization is a critical component of
PAH pathophysiology, and herein, we utilize fate mapping and
develop an approach for generating a timeline of key molecular
and cellular events during hypoxia-induced muscularization of
specific distal arteriole beds.
Our fate-mapping results indicate that the vast majority of
hypoxia-induced distal arteriole SMCs derive from pre-existing
smooth muscle. Previous studies have also proposed other
potential cellular sources for the excess SMCs in PH, including
fibroblasts, pericytes, ECs, and hematopoietic cells (Hayashida
et al., 2005; Morrell et al., 2009; Qiao et al., 2013; Spees et al.,
2008; Stenmark et al., 2006). The only prior lineage analysis in
PH was recently reported and used constitutive Cre’s driven
by the promoters of vascular endothelial-cadherin or Tie2 in
the context of a new murine PH model of surgical pneumonec-
tomy followed by monocrotaline injection (Qiao et al., 2013).
The authors conclude that in this PH model, a minority of PA
SMCs derive from ECs; however, the contribution of such trans-
differentiation to distal pulmonary arteriole muscularization is not
clear given anatomical considerations, non-EC recombination,
and potential PA EC transdifferentiation to SMCs during embryo-
genesis (Arciniegas et al., 2000; Jiao et al., 2006; Morimoto et al.,
2010; Qiao et al., 2013). In addition, bone marrow transplant
studies suggest that bone marrow-derived cells contribute to aarterioles in the regions noted in (A) at the indicated time points. At least eight
of SMA+ cells scored for each condition by arteriole type was P (each condition,
ys, 20; 7 days, 39; 14 days, 88; 21 days, 130). Note the robust increase in distal
ersus hypoxia P and M, p < 0.005. Error bars indicate SD.
oxia day 7 stained as in (A). Asterisks indicate BrdU+SMA+ distal arteriole cells
onary arteriole muscularization. Under normoxic conditions, M (and P) arteriole
gly, a few rare SMA+SMMHC+PDGFR-b+ cells (yellow) are located just proximal
s have started to migrate distally across the M-D border and dedifferentiate as
. These cells are proliferative (dividing cell) by day 7 and continue to migrate
differentiate as indicated by the expression of SMMHC and downregulation of
is coated with nonproliferative, differentiated SMCs (gray) and, similar to the
new muscular-unmuscular transition zone.
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number of lung cell types in PH, including SMA+ vascular
cells (Hayashida et al., 2005; Spees et al., 2008), which is po-
tentially consistent with our findings as SMA is expressed in
select bone marrow-derived cells (Peled et al., 1991). Non-
smooth-muscle sources are likely to provide at most a minor
contribution to the number of distal arteriole SMCs, yet further
experiments are indicated that utilize rigorous fate mapping
(with conditional cell-specific labeling when appropriate) and
analyze the distal arteriole beds delineated herein.
Although alveolar myofibroblasts are extremely rare in the
normal adult, they are present in the lungs of PH patients and
are implicated in disease pathophysiology (Chen et al., 2006;
Choi, 2010; Kapanci et al., 1990). Previously, it was shown that
mice exposed to 6 weeks of hypoxia have increased alveolar
SMA+ cells, and their formation is enhanced by transforming
growth factor b-dependent signaling (Chen et al., 2006). Herein,
we find a significant increase in alveolar myofibroblasts by
7 days of hypoxia, and by 21 days, most of these SMA+ alveolar
cells also express SMMHC, traditionally considered a specific
marker of SMCs (Miano et al., 1994). Moreover, in contrast to
distal pulmonary arteriole SMCs, we show that the vast majority
of alveolar myofibroblasts derive fromSMA cells and that prolif-
eration of SMA+ myofibroblasts is very rare. Thus, our findings
with regard to hypoxia-induced alveolar myofibroblasts are the
following: (1) early appearance of myofibroblasts, (2) SMMHC
expression, (3) predominant SMA cellular origin, and (4) negli-
gible proliferation. Taken together, we show that hypoxia induces
robust and early expansion of an alveolar SMA+SMMHC+ myofi-
broblast population largely through differentiation of SMA cells.
Our approach of analyzing specific distal pulmonary arteriole
beds over time during PH onset is a paradigm shift from standard
analysis of random lung sections and allows for the evaluation of
cellular and molecular dynamics during arteriole musculariza-
tion. In response to hypoxia, our results indicate that pre-existing
differentiated SMCs dedifferentiate and then follow a very similar
muscularization program to that of the developing PA (schematic
Figure 4D) (Greif et al., 2012). Initially, SMMHC+SMA+ cells
downregulate SMMHC and upregulate PDGFR-b expression
and migrate across the M-D arteriole border (day 3). These distal
arteriole undifferentiated cells then proliferate robustly and
continue to migrate distally (day 7). By 14 days of hypoxia, the
distal arteriole SMA+ cells begin to reduce PDGFR-b expression
and upregulate SMMHC, and at 21 days, the distal arteriole is
muscularized by differentiated, mature SMCs, similar to the nor-
moxic middle arteriole. These newly muscularized distal arteri-
oles form a single layer of SMCs, and thus pathological SMA+
progenitors migrate axially along the EC tube as in development,
but in contrast to large PA morphogenesis, they do not migrate
radially outward (Greif et al., 2012). Similar to development (Hell-
stro¨m et al., 1999), we hypothesize that signals emanating from
ECs (in this case from the very distal arteriole in proximity to the
capillary transition) drive the directed axial SMCmigration. Inter-
estingly, we consistently detect a few SMA+SMMHC+PDGFR-b+
cells adjacent to the arteriole muscular-unmuscular transition in
normoxia (Figures 4D and S4A). We propose that these cells are
primed to dedifferentiate, migrate and proliferate in response to
insults such as hypoxia and thus, may be important players in
initiating pathological distal arteriole muscularization. Addition-816 Cell Reports 6, 809–817, March 13, 2014 ª2014 The Authorsally, rodents returned to normoxia after extended hypoxia
exposure have been shown to undergo reverse remodeling
with a reduction in PA muscularization (Meyrick and Reid,
1980; Sakao et al., 2010), and an in-depth analysis of this
intriguing process will be a focus of future investigation. In
sum, we suggest that the in vivo reductionist approach utilized
herein should be adopted widely to the study of vascular disease
because, as in this initial example of PH, it promises to identify
important previously unknown pathological events that are
potential targets for novel therapeutics.
EXPERIMENTAL PROCEDURES
Animals and Tamoxifen Treatment
All animal experiments were approved by the Institutional Animal Care andUse
Committee at Yale University. Mouse strains are described in Supplemental
Information. For fate mapping, 2- to 4-month-old mice were injected with
1 mg tamoxifen per day for 5 days and then allowed to rest for 5 days prior
to hypoxia treatment.
Hypoxia Treatment and Assessment of Right Ventricular Systolic
Pressure and Hypertrophy
Mice were exposed to hypoxia (FiO2 10%) for up to 3 weeks in a rodent
hypoxia chamber with a calibrated oxygen controller and sensor (BioSpherix).
Right ventricular (equivalent to PA) systolic pressures were measured by in-
serting a catheter (Millar Instruments) into the right ventricle via the right jugular
vein, andmicewere then sacrificed, the heart dissected, and theweight ratio of
the right ventricle/(left ventricle + septum) assessed (Hayashida et al., 2005;
Kim et al., 2013).
BrdU Labeling
For the analysis of cell proliferation, mice were intraperitoneally injected with
bromodeoxyuridine (BrdU; 100 mg/kg body weight). Four hours after injection,
mice were sacrificed, and the lung tissue was prepared for immunohistochem-
istry as described below except for 30 min incubation in 2M HCl prior to
sectioning.
Lung Preparation
Mice were sacrificed by isoflurane inhalation. The pulmonary vasculature was
flushed with PBS by inserting a needle connected to a reservoir into the right
ventricle and allowing the fluid to drain through an incision in the thoracic aorta.
Animals were then tracheostomized with an angiocatheter, and the lungs
inflated with 2% low-melt agarose in PBS. Agarose-filled lungs were solidified
by 30 min incubation in ice-cold PBS. Lobes were separated, fixed in Dent’s
fixative (4:1 methanol:DMSO) at 4C overnight, washed in 100% methanol,
bleached in 5% H2O2 and rehydrated into PBS. Rehydrated lungs were vibra-
tome-sectioned at a thickness of 150 mm.
Immunohistochemical Analysis
Vibratome sections were blocked with 5% normal goat serum in 0.5% Triton
X-100/PBS (PBS-T) at 4C overnight. Sections were then incubated in primary
antibodies for 1–3 days at 4C, washed 5 3 1 hr in PBS-T, incubated in
secondary antibodies overnight at 4C, washed 33 1 hr in PBS-T, and placed
on slides in mounting media (DAKO). Antibodies are listed in Supplemental
Experimental Procedures.
Imaging
Samples were imaged on confocal microscopes (Perkin Elmer UltraView VOX
spinning disc or Leica SP5 point-scanning). Volocity software (Perkin Elmer)
was used to process images and count cells, and Adobe Photoshop was
used to process images.
Statistical Analysis
Multifactor ANOVA and post hoc test with Bonferroni corrections were used to
analyze the data (StatPlus software). All data are presented as mean ± SD.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2014.01.042.
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